Focused on life sciences commercialization, he translates R&D breakthroughs into revenue-generating solutions. Highlights include 65+ IP-led alliances and 9 product launches, contributing to $2B+ in exits. Advancing AI/ML-powered precision medicine platforms, Dr. Hauser creates shareholder value through strategic roadmapping, partnerships, and scalable execution.
